Literature DB >> 26935060

miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2.

Shuo Zhang1,2, Lei Gao1,2, Asmitananda Thakur1,2,3,4, Puyu Shi1,2, Feng Liu1,2, Jing Feng1,2, Ting Wang1,2, Yiqian Liang1,2, Johnson J Liu5, Mingwei Chen6,7, Hui Ren8,9.   

Abstract

MicroRNAs (miRNAs) play a critical role in cancer development and progression. Deregulated expression of miR-204 has been reported in several cancers, but the mechanism through which miR-204 modulates human non-small cell lung cancer (NSCLC) is largely unknown. In this study, we investigate the expression and functional role of miR-204 in human NSCLC tissues and cell lines. RNA isolation, qRT-PCR, MTT, colony formation assay, cell cycle assay, cell apoptosis assay, cell migration assay, and Western blot were performed. Statistical analysis was performed using SPSS 18.0 software and statistical significance was accepted at p value <0.05. miR-204 level was significantly reduced in NSCLC tissues as compared to that of non-neoplastic tissues. Transient over-expression of miR-204 by transfecting with miR-204 mimics suppressed NSCLC cell proliferation, migration, and induced apoptosis and G1 arrest, whereas inhibition of miR-204 showed the converse effects. Additionally, activating transcription factor 2 (ATF2), an important transcription factor, was demonstrated as a potential target gene of miR-204. Subsequent investigations found a negative correlation between miR-204 level and ATF2 expression in NSCLC tissue samples. Moreover, we observed that miR-204 expression inversely affected endogenous ATF2 expression at both mRNA and protein levels in vitro. Taken together, miR-204 may act as a tumor suppressor by directly targeting ATF2 in NSCLC.

Entities:  

Keywords:  ATF2; Apoptosis; Migration; NSCLC; miR-204

Mesh:

Substances:

Year:  2016        PMID: 26935060     DOI: 10.1007/s13277-016-4906-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  The p38 transduction pathway in prostatic neoplasia.

Authors:  M Ricote; I García-Tuñón; F Bethencourt; B Fraile; P Onsurbe; R Paniagua; M Royuela
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

2.  Promoter region of the human CRE-BP1 gene encoding the transcriptional regulator binding to the cyclic AMP response element.

Authors:  T Nagase; T Sudo; T Maekawa; T Yoshimura; J Fujisawa; M Yoshida; S Ishii
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

Review 3.  MicroRNAs in human lung cancer.

Authors:  Sung-Min Kang; Heon-Jin Lee
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-28

4.  Multimodality therapy in the treatment of lung cancer.

Authors:  M Patricia Rivera
Journal:  Semin Respir Crit Care Med       Date:  2004       Impact factor: 3.119

5.  Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes.

Authors:  Qin Ma; Xinying Li; Dustin Vale-Cruz; Mark L Brown; Frank Beier; Phyllis LuValle
Journal:  J Cell Biochem       Date:  2007-05-15       Impact factor: 4.429

Review 6.  The role of ATF-2 in oncogenesis.

Authors:  Spiros A Vlahopoulos; Stella Logotheti; Dimitris Mikas; Athina Giarika; Vassilis Gorgoulis; Vassilis Zoumpourlis
Journal:  Bioessays       Date:  2008-04       Impact factor: 4.345

7.  MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.

Authors:  Chai San Ho; Seow Hui Yap; Neoh Hun Phuah; Lionel L A In; Noor Hasima
Journal:  Lung Cancer       Date:  2013-12-06       Impact factor: 5.705

8.  Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice.

Authors:  Shuangwei Li; Sergei Ezhevsky; Antimone Dewing; Matthew H Cato; Marzia Scortegagna; Anindita Bhoumik; Wolfgang Breitwieser; Demetrious Braddock; Alexey Eroshkin; Jianfei Qi; Meifan Chen; Jae-Young Kim; Stephen Jones; Nic Jones; Robert Rickert; Ze'ev A Ronai
Journal:  Genes Cancer       Date:  2010-04-01

9.  A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells.

Authors:  Miao Ding; Biaoyang Lin; Tao Li; Yuanyuan Liu; Yuhua Li; Xiaoyu Zhou; Maohua Miao; Jinfa Gu; Hongjie Pan; Fen Yang; Tianqi Li; Xin Yuan Liu; Runsheng Li
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  miRNA biogenesis: biological impact in the development of cancer.

Authors:  Sandra L Romero-Cordoba; Ivan Salido-Guadarrama; Mauricio Rodriguez-Dorantes; Alfredo Hidalgo-Miranda
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

View more
  18 in total

1.  Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer.

Authors:  Shilong Zhang; Xinxin Dong; Tongyu Ji; Guoxiao Chen; Lei Shan
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Serum microRNA-204 levels are associated with long-term cardiovascular disease risk based on the Framingham risk score in patients with type 2 diabetes: results from an observational study.

Authors:  Rui Wang; Yao-Dong Ding; Wen Gao; Yu-Qiang Pei; Jia-Xin Yang; Ying-Xin Zhao; Xiao-Li Liu; Hua Shen; Shuo Zhang; Lei Yu; Hai-Long Ge
Journal:  J Geriatr Cardiol       Date:  2020-06       Impact factor: 3.327

3.  microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1).

Authors:  Guanlin Wu; Jian Wang; Guojun Chen; Xing Zhao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

4.  MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells.

Authors:  Ying Liang; Wen-Yu Tian; Juan-Juan Huang; Ling-Xi Gao; Xiao-Hui Fan
Journal:  Oncol Lett       Date:  2021-04-21       Impact factor: 2.967

5.  The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.

Authors:  Zhi-Hua Ye; Dong-Yue Wen; Xiao-Yong Cai; Liang Liang; Pei-Rong Wu; Hui Qin; Hong Yang; Yun He; Gang Chen
Journal:  Oncotarget       Date:  2017-10-23

6.  Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells.

Authors:  Fushi Han; Dongdong Huang; Xinghong Huang; Wei Wang; Shusong Yang; Shuzhen Chen
Journal:  J Cell Mol Med       Date:  2020-05-31       Impact factor: 5.310

7.  microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.

Authors:  Weizhong Han; Xiaoxia Ren; Yupeng Yang; Haixia Li; Lin Zhao; Zhaoxia Lin
Journal:  Thorac Cancer       Date:  2020-05-04       Impact factor: 3.500

8.  MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway.

Authors:  Tao Wang; Zhenyu Cai; Guolin Hong; Gangsen Zheng; Yu Huang; Shun Zhang; Jinhua Dai
Journal:  Mol Med Rep       Date:  2017-09-08       Impact factor: 2.952

9.  Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.

Authors:  Yu Jin Kim; Ki-Chul Hwang; Sang Woo Kim; Yong Chan Lee
Journal:  Int J Med Sci       Date:  2018-03-14       Impact factor: 3.738

10.  Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.

Authors:  Laura Sonea; Mihail Buse; Diana Gulei; Anca Onaciu; Ioan Simon; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Curr Genomics       Date:  2018-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.